The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma

A high-performance liquid chromatography-fluorescence detection (HPLC-FLD) method for determination of the fluoroquinolones norfloxacin (NOR), ciprofloxacin (CIP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma has been successfully developed. The detection was optimized with a dual w...

Full description

Bibliographic Details
Main Authors: Diep Thi Minh Nguyen, Tuan Anh Vu, Dien Xuan Luong, Truong Xuan Nguyen
Format: Article
Language:English
Published: Vietnam Ministry of Science and Technology 2022-06-01
Series:Vietnam Journal of Science, Technology and Engineering
Subjects:
Online Access:https://vietnamscience.vjst.vn/index.php/vjste/article/view/328
_version_ 1797937799538671616
author Diep Thi Minh Nguyen
Tuan Anh Vu
Dien Xuan Luong
Truong Xuan Nguyen
author_facet Diep Thi Minh Nguyen
Tuan Anh Vu
Dien Xuan Luong
Truong Xuan Nguyen
author_sort Diep Thi Minh Nguyen
collection DOAJ
description A high-performance liquid chromatography-fluorescence detection (HPLC-FLD) method for determination of the fluoroquinolones norfloxacin (NOR), ciprofloxacin (CIP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma has been successfully developed. The detection was optimized with a dual wavelength excitation and emission fluorescence detector. Analytical wavelengths of λex/λem=290/500 nm (for LEVO and MOXI) and λex/λem=280/445 nm (for NOR and CIP) were found when measuring fluoroquinolones in the mixture. The plasma sample was pre-treated during the deproteinization step using methanol. This method was validated by linearity in the ranges of 0.05-15; 0.05-10; 0.05-15; and 0.10-10 µg ml-1 with limits of detection of 0.0071; 0.0080; 0.0074; and 0.0171 µg ml-1 for NOR, CIP, LEVO, and MOXI, respectively. Further, the HPLC-FLD method was proven to be precise and accurate with relative standard deviations lower than 6% and recoveries ranging from 92.5-105.4% for all four fluoroquinolones. Therefore, the proposed HPLC-FLD method provides an alternative approach for the simultaneous analysis of fluoroquinolones in plasma.A high-performance liquid chromatography-fluorescence detection (HPLC-FLD) method for determination of the fluoroquinolones norfloxacin (NOR), ciprofloxacin (CIP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma has been successfully developed. The detection was optimized with a dual wavelength excitation and emission fluorescence detector. Analytical wavelengths of λex/λem=290/500 nm (for LEVO and MOXI) and λex/λem=280/445 nm (for NOR and CIP) were found when measuring fluoroquinolones in the mixture. The plasma sample was pre-treated during the deproteinization step using methanol. This method was validated by linearity in the ranges of 0.05-15; 0.05-10; 0.05-15; and 0.10-10 µg ml-1 with limits of detection of 0.0071; 0.0080; 0.0074; and 0.0171 µg ml-1 for NOR, CIP, LEVO, and MOXI, respectively. Further, the HPLC-FLD method was proven to be precise and accurate with relative standard deviations lower than 6% and recoveries ranging from 92.5-105.4% for all four fluoroquinolones. Therefore, the proposed HPLC-FLD method provides an alternative approach for the simultaneous analysis of fluoroquinolones in plasma.
first_indexed 2024-04-10T18:50:52Z
format Article
id doaj.art-e8eb8388c1af4f41856629b81c27599d
institution Directory Open Access Journal
issn 2525-2461
2615-9937
language English
last_indexed 2024-04-10T18:50:52Z
publishDate 2022-06-01
publisher Vietnam Ministry of Science and Technology
record_format Article
series Vietnam Journal of Science, Technology and Engineering
spelling doaj.art-e8eb8388c1af4f41856629b81c27599d2023-02-01T08:12:41ZengVietnam Ministry of Science and TechnologyVietnam Journal of Science, Technology and Engineering2525-24612615-99372022-06-0164210.31276/VJSTE.64(2).16-20The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasmaDiep Thi Minh Nguyen0Tuan Anh Vu1Dien Xuan Luong2Truong Xuan Nguyen3School of Chemical Engineering, Hanoi University of Science and TechnologySchool of Chemical Engineering, Hanoi University of Science and TechnologySchool of Chemical Engineering, Hanoi University of Science and TechnologySchool of Chemical Engineering, Hanoi University of Science and Technology A high-performance liquid chromatography-fluorescence detection (HPLC-FLD) method for determination of the fluoroquinolones norfloxacin (NOR), ciprofloxacin (CIP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma has been successfully developed. The detection was optimized with a dual wavelength excitation and emission fluorescence detector. Analytical wavelengths of λex/λem=290/500 nm (for LEVO and MOXI) and λex/λem=280/445 nm (for NOR and CIP) were found when measuring fluoroquinolones in the mixture. The plasma sample was pre-treated during the deproteinization step using methanol. This method was validated by linearity in the ranges of 0.05-15; 0.05-10; 0.05-15; and 0.10-10 µg ml-1 with limits of detection of 0.0071; 0.0080; 0.0074; and 0.0171 µg ml-1 for NOR, CIP, LEVO, and MOXI, respectively. Further, the HPLC-FLD method was proven to be precise and accurate with relative standard deviations lower than 6% and recoveries ranging from 92.5-105.4% for all four fluoroquinolones. Therefore, the proposed HPLC-FLD method provides an alternative approach for the simultaneous analysis of fluoroquinolones in plasma.A high-performance liquid chromatography-fluorescence detection (HPLC-FLD) method for determination of the fluoroquinolones norfloxacin (NOR), ciprofloxacin (CIP), levofloxacin (LEVO), and moxifloxacin (MOXI) in human plasma has been successfully developed. The detection was optimized with a dual wavelength excitation and emission fluorescence detector. Analytical wavelengths of λex/λem=290/500 nm (for LEVO and MOXI) and λex/λem=280/445 nm (for NOR and CIP) were found when measuring fluoroquinolones in the mixture. The plasma sample was pre-treated during the deproteinization step using methanol. This method was validated by linearity in the ranges of 0.05-15; 0.05-10; 0.05-15; and 0.10-10 µg ml-1 with limits of detection of 0.0071; 0.0080; 0.0074; and 0.0171 µg ml-1 for NOR, CIP, LEVO, and MOXI, respectively. Further, the HPLC-FLD method was proven to be precise and accurate with relative standard deviations lower than 6% and recoveries ranging from 92.5-105.4% for all four fluoroquinolones. Therefore, the proposed HPLC-FLD method provides an alternative approach for the simultaneous analysis of fluoroquinolones in plasma. https://vietnamscience.vjst.vn/index.php/vjste/article/view/328dual wavelength excitation and emissionfluoroquinolonesHPLC-FLD, plasma
spellingShingle Diep Thi Minh Nguyen
Tuan Anh Vu
Dien Xuan Luong
Truong Xuan Nguyen
The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
Vietnam Journal of Science, Technology and Engineering
dual wavelength excitation and emission
fluoroquinolones
HPLC-FLD, plasma
title The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
title_full The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
title_fullStr The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
title_full_unstemmed The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
title_short The development of HPLC dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
title_sort development of hplc dual wavelength fluorescence detection method for the simultaneous determination of four fluoroquinolones in human plasma
topic dual wavelength excitation and emission
fluoroquinolones
HPLC-FLD, plasma
url https://vietnamscience.vjst.vn/index.php/vjste/article/view/328
work_keys_str_mv AT diepthiminhnguyen thedevelopmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT tuananhvu thedevelopmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT dienxuanluong thedevelopmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT truongxuannguyen thedevelopmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT diepthiminhnguyen developmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT tuananhvu developmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT dienxuanluong developmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma
AT truongxuannguyen developmentofhplcdualwavelengthfluorescencedetectionmethodforthesimultaneousdeterminationoffourfluoroquinolonesinhumanplasma